Health and Family Welfare Government Departments Closing in 0 days TDR #40902225

E-Tender For Rate Contract For Supply Of Ionic And Non-Ionic Contrast Media For U N Mehta Institute Of Cardiology And Research Centre (Affiliated To B. J. Medical College & Nabh Accredited) Ahmedabad, Gujarat, India.- Iodixanol,Iodixanol,Iodixanol,Iodixan

Issued by Government Departments · Asarwa, Gujarat
Tender Value
3.23 Crore
Estimated cost
Bid Submission
26 Dec 2023
0 days left
EMD
6.46 Lakhs
Bank guarantee accepted
Document Fee
8850
Non-refundable
Tender Type
Online

Tender Overview

Organization
Click here to view tendering authority
Tender ID
Click here to view tender id
Competition Type
NCB
Bidding Type
Tender
Location / State
Asarwa → Gujarat
EMD Exemption
Not Available
Quantity
Not Available
Website
Click here to view website
Contact Person
Click here to view contact person
Address
Click here to view address

Project Description

E-Tender For Rate Contract For Supply Of Ionic And Non-Ionic Contrast Media For U N Mehta Institute Of Cardiology And Research Centre ( Affiliated To B. J. Medical College & Nabh Accredited ) Ahmedabad, Gujarat, India.- Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Gastro Enteral Solution : Sodium Amidotrizoate 10 G, Meglumine Amidotrizoate 66G ( Sodium Diatrizoate And Meglumine Diatrizoate ) , Gastro Enteral Solution : Sodium Amidotrizoate 10 G, Meglumine Amidotrizoate 66G ( Sodium Diatrizoate And Meglumine Diatrizoate ) , Ultra Sound Contrast: Micro Bubbles, Ultra Sound Contrast: Micro Bubbles, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Hepatobiliary Agents, Hepatobiliary Agents, Hepatobiliary Agents, Hepatobiliary Agents, Target ( Organ ) Specific Contrast, Target ( Organ ) Specific Contrast, Target ( Organ ) Specific Contrast, Target ( Organ ) Specific Contrast

Corrigendum

Sr No Corrigendum Date Corrigendum Type New Submission Date
1 12-Dec-2023 26-Dec-2023

BOQ

Sl. No.Item TitleIodine mgI/ml
1IODIXANOL270 mgI/ml
2IODIXANOL270 mgI/ml
3IODIXANOL270 mgI/ml
4IODIXANOL270 mgI/ml
5IODIXANOL270 mgI/ml
6IODIXANOL270 mgI/ml
7IODIXANOL320 mgI/ml
8IODIXANOL320 mgI/ml
9IODIXANOL320 mgI/ml
10IODIXANOL320 mgI/ml
11IODIXANOL320 mgI/ml
12IODIXANOL320 mgI/ml
13IOHEXOL300 mgI/ml
14IOHEXOL300 mgI/ml
15IOHEXOL300 mgI/ml
16IOHEXOL300 mgI/ml
17IOHEXOL300 mgI/ml
18IOHEXOL300 mgI/ml
19IOHEXOL300 mgI/ml
20IOHEXOL300 mgI/ml
21IOHEXOL350 mgI/ml
22IOHEXOL350 mgI/ml
23IOHEXOL350 mgI/ml
24IOHEXOL350 mgI/ml
25IOHEXOL350 mgI/ml
26IOHEXOL350 mgI/ml
27IOHEXOL350 mgI/ml
28IOHEXOL350 mgI/ml
29IOPAMIDOL300 mgI/ml
30IOPAMIDOL300 mgI/ml
31IOPAMIDOL300 mgI/ml
32IOPAMIDOL300 mgI/ml
33IOPAMIDOL370 mgI/ml
34IOPAMIDOL370 mgI/ml
35IOPAMIDOL370 mgI/ml
36IOPAMIDOL370 mgI/ml
37IOVERSOL320 mgI/ml
38IOVERSOL320 mgI/ml
39IOVERSOL320 mgI/ml
40IOVERSOL320 mgI/ml
41IOVERSOL350 mgI/ml
42IOVERSOL350 mgI/ml
43IOVERSOL350 mgI/ml
44IOVERSOL350 mgI/ml
45IOMEPROL300 mgI/ml
46IOMEPROL300 mgI/ml
47IOMEPROL300 mgI/ml
48IOMEPROL300 mgI/ml
49IOMEPROL350 mgI/ml
50IOMEPROL350 mgI/ml
51IOMEPROL350 mgI/ml
52IOMEPROL350 mgI/ml
53IOMEPROL350 mgI/ml
54IOMEPROL350 mgI/ml
55IOMEPROL400 mgI/ml
56IOMEPROL400 mgI/ml
57IOMEPROL400 mgI/ml
58IOMEPROL400 mgI/ml
59IOMEPROL400 mgI/ml
60IOMEPROL400 mgI/ml
61IOPROMIDE300 mgI/ml
62IOPROMIDE300 mgI/ml
63IOPROMIDE300 mgI/ml
64IOPROMIDE300 mgI/ml
65IOPROMIDE350 mgI/ml
66IOPROMIDE350 mgI/ml
67IOPROMIDE350 mgI/ml
68IOPROMIDE350 mgI/ml
69IOPROMIDE400 mgI/ml
70IOPROMIDE400 mgI/ml
71IOPROMIDE400 mgI/ml
72IOPROMIDE400 mgI/ml
73IOXILAN300 mgI/ml
74IOXILAN300 mgI/ml
75IOXILAN300 mgI/ml
76IOXILAN300 mgI/ml
77IOXILAN350 mgI/ml
78IOXILAN350 mgI/ml
79IOXILAN350 mgI/ml
80IOXILAN350 mgI/ml
81Meglumine Diatrizoate =52.1 % W/V, SodiumDiatrizoate = 7.9% W/V370 mgI/ml
82Meglumine Diatrizoate =52.1 % W/V, SodiumDiatrizoate = 7.9% W/V370 mgI/ml
83Meglumine Diatrizoate =52.1 % W/V, SodiumDiatrizoate = 7.9% W/V370 mgI/ml
84Meglumine Diatrizoate =52.1 % W/V, SodiumDiatrizoate = 7.9% W/V370 mgI/ml
85Meglumine Diatrizoate =52.1 % W/V, SodiumDiatrizoate = 7.9% W/V370 mgI/ml
86Meglumine Diatrizoate =52.1 % W/V, SodiumDiatrizoate = 7.9% W/V370 mgI/ml
87Gastro enteral solution : Sodium Amidotrizoate 10 g, Meglumine Amidotrizoate66g (Sodium Diatrizoate andMeglumine Diatrizoate)292 mgI/ml
88Gastro enteral solution : Sodium Amidotrizoate 10 g, Meglumine Amidotrizoate66g (Sodium Diatrizoate andMeglumine Diatrizoate)292 mgI/ml
89Ultra Sound Contrast: Micro Bubbles? Microbubbles sizes ~1-4 um? Gass encapsulated in pliable shell, usually a lipid monolayer (albumin, galactose, or polymers)? Low solubility perfluorocarbon gass (air, nitrogen)? 90% DLess than 6 um and 99% DLess than 11 um? Gass: Sulphur hexa fluoride, inert and non-toxic
90Ultra Sound Contrast: Micro Bubbles? Microbubbles sizes ~1-4 um? Gass encapsulated in pliable shell, usually a lipid monolayer (albumin, galactose, or polymers)? Low solubility perfluorocarbon gass (air, nitrogen)? 90% DLess than 6 um and 99% DLess than 11 um? Gass: Sulphur hexa fluoride, inert and non-toxic
91Linear Ionic MRI Contrast MediaIonic Gadopentetate for IV useConcentration 0.5 m mol/ml
92Linear Ionic MRI Contrast MediaIonic Gadopentetate for IV useConcentration 0.5 m mol/ml
93Linear Ionic MRI Contrast MediaIonic Gadopentetate for IV useConcentration 0.5 m mol/ml
94Linear Ionic MRI Contrast MediaIonic Gadopentetate for IV useConcentration 0.5 m mol/ml
95Linear Ionic MRI Contrast MediaIonic Gadobenate for IV useConcentration 0.5 m mol/ml
96Linear Ionic MRI Contrast MediaIonic Gadobenate for IV useConcentration 0.5 m mol/ml
97Linear Ionic MRI Contrast MediaIonic Gadobenate for IV useConcentration 0.5 m mol/ml
98Linear Ionic MRI Contrast MediaIonic Gadobenate for IV useConcentration 0.5 m mol/ml
99Linear Ionic MRI Contrast MediaIonic Gadoxetate for IV useConcentration 0.25 m mol/ml
100Linear Ionic MRI Contrast MediaIonic Gadoxetate for IV useConcentration 0.25 m mol/ml
101Linear Ionic MRI Contrast MediaIonic Gadoxetate for IV useConcentration 0.25 m mol/ml
102Linear Ionic MRI Contrast MediaIonic Gadoxetate for IV useConcentration 0.25 m mol/ml
103Linear Ionic MRI Contrast MediaIonic Gadofosveset for IV useConcentration 0.25 m mol/ml
104Linear Ionic MRI Contrast MediaIonic Gadofosveset for IV useConcentration 0.25 m mol/ml
105Linear Ionic MRI Contrast MediaIonic Gadofosveset for IV useConcentration 0.25 m mol/ml
106Linear Ionic MRI Contrast MediaIonic Gadofosveset for IV useConcentration 0.25 m mol/ml
107Macrocyclic Ionic MRI Contrast MediaIonic Gadoterate for IV useConcentration 0.5 m mol/ml
108Macrocyclic Ionic MRI Contrast MediaIonic Gadoterate for IV useConcentration 0.5 m mol/ml
109Macrocyclic Ionic MRI Contrast MediaIonic Gadoterate for IV useConcentration 0.5 m mol/ml
110Macrocyclic Ionic MRI Contrast MediaIonic Gadoterate for IV useConcentration 0.5 m mol/ml
111Linear Non-Ionic MRI Contrast MediaNon Ionic Gadodiamide for IV useConcentration 0.5 m mol/ml
112Linear Non-Ionic MRI Contrast MediaNon Ionic Gadodiamide for IV useConcentration 0.5 m mol/ml
113Linear Non-Ionic MRI Contrast MediaNon Ionic Gadodiamide for IV useConcentration 0.5 m mol/ml
114Linear Non-Ionic MRI Contrast MediaNon Ionic Gadodiamide for IV useConcentration 0.5 m mol/ml
115Linear Non-Ionic MRI Contrast MediaNon Ionic Gadoversetamide for IV useConcentration 0.5 m mol/ml
116Linear Non-Ionic MRI Contrast MediaNon Ionic Gadoversetamide for IV useConcentration 0.5 m mol/ml
117Linear Non-Ionic MRI Contrast MediaNon Ionic Gadoversetamide for IV useConcentration 0.5 m mol/ml
118Linear Non-Ionic MRI Contrast MediaNon Ionic Gadoversetamide for IV useConcentration 0.5 m mol/ml
119Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadobutrol for IV useConcentration 1 m mol/ml
120Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadobutrol for IV useConcentration 1 m mol/ml
121Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadobutrol for IV useConcentration 1 m mol/ml
122Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadobutrol for IV useConcentration 1 m mol/ml
123Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadoteridol for IV useConcentration 0.5 m mol/ml
124Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadoteridol for IV useConcentration 0.5 m mol/ml
125Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadoteridol for IV useConcentration 0.5 m mol/ml
126Macrocyclic Non-Ionic MRI Contrast MediaNon Ionic Gadoteridol for IV useConcentration 0.5 m mol/ml
127Blood Pool AgentsAlbumin binding gadolinium complexes
128Blood Pool AgentsAlbumin binding gadolinium complexes
129Blood Pool AgentsAlbumin binding gadolinium complexes
130Blood Pool AgentsAlbumin binding gadolinium complexes
131Blood Pool AgentsPolymeric gadolinium complexes
132Blood Pool AgentsPolymeric gadolinium complexes
133Blood Pool AgentsPolymeric gadolinium complexes
134Blood Pool AgentsPolymeric gadolinium complexes
135Hepatobiliary Agentsgadolinium Chelate-Gadobenate Dimegluminehaving hepatobilliary excreationFor IV UseConcentration 529 MG/MLMention Serum Elimination Half Life
136Hepatobiliary Agentsgadolinium Chelate-Gadobenate Dimegluminehaving hepatobilliary excreationFor IV UseConcentration 529 MG/MLMention Serum Elimination Half Life
137Hepatobiliary Agentsgadolinium Chelate-Gadobenate Dimegluminehaving hepatobilliary excreationFor IV UseConcentration 529 MG/MLMention Serum Elimination Half Life
138Hepatobiliary Agentsgadolinium Chelate-Gadobenate Dimegluminehaving hepatobilliary excreationFor IV UseConcentration 529 MG/MLMention Serum Elimination Half Life
139Target (Organ) Specific ContrastContrast Media for Lymphnode, Myocardium etc..
140Target (Organ) Specific ContrastContrast Media for Lymphnode, Myocardium etc..
141Target (Organ) Specific ContrastContrast Media for Lymphnode, Myocardium etc..
142Target (Organ) Specific ContrastContrast Media for Lymphnode, Myocardium etc..

AI Tender Summary

OUR REF NO 40902225
AUTHORITY Government Departments
TENDER VALUE 3.23 Crore
LAST DATE 26-12-2023
Authority
Authority Name U N Mehta Institute Of Cardiology & Research Center
Work Description E-Tender For Rate Contract For Supply Of Ionic And Non-Ionic Contrast Media For U N Mehta Institute Of Cardiology And Research Centre ( Affiliated To B. J. Medical College & Nabh Accredited ) Ahmedabad, Gujarat, India.- Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iodixanol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iohexol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Iopamidol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Ioversol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iomeprol, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Iopromide, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Ioxilan, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Meglumine Diatrizoate = 52.1 % W / V, Sodium Diatrizoate = 7.9% W / V, Gastro Enteral Solution : Sodium Amidotrizoate 10 G, Meglumine Amidotrizoate 66G ( Sodium Diatrizoate And Meglumine Diatrizoate ) , Gastro Enteral Solution : Sodium Amidotrizoate 10 G, Meglumine Amidotrizoate 66G ( Sodium Diatrizoate And Meglumine Diatrizoate ) , Ultra Sound Contrast: Micro Bubbles, Ultra Sound Contrast: Micro Bubbles, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Linear Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Macrocyclic Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Linear Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Macrocyclic Non-Ionic Mri Contrast Media, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Blood Pool Agents, Hepatobiliary Agents, Hepatobiliary Agents, Hepatobiliary Agents, Hepatobiliary Agents, Target ( Organ ) Specific Contrast, Target ( Organ ) Specific Contrast, Target ( Organ ) Specific Contrast, Target ( Organ ) Specific Contrast
Basic Detail
Tender No 29 of 2023
Bidding Type Tender
Location
City Asarwa
State Gujarat
Key Dates
Publish Date 12 Dec 2023
Submission Date 26 Dec 2023
Open Date 01 Jan 0001
Finance
Tender Value 3.23 Crore
Tender Fee 8850
EMD 6.46 Lakhs
Exemption Not Available
Document List
436070db-9674-458c-8593-648b014e568e.html
Technical Compliance Sheet .xls
Tender document.pdf
AI-generated summary — verify details from the official tender portal before submission.

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Dec 12, 2023
11:30 IST

Tender Published

Tender notice published.

Completed
Dec 26, 2023
18:00 IST

Corrigendum-1 Issued

Clarifications on tender conditions and amendments issued.

Completed
Dec 26, 2023
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Completed

Tender Documents

Download All (ZIP) ↓
html

436070db-9674-458c-8593-648b014e568e.html

xls

Technical Compliance Sheet .xls

pdf

Tender document.pdf

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders